KONINKLIJKE PHILIPS NV ADR

NYSE: PHG (Koninklijke Philips N.V. NY Reg)

最近更新时间: 22 Dec, 2024, 3:33PM

25.11

0.08 (0.32%)

前收盘价格 25.03
收盘价格 24.90
成交量 563,137
平均成交量 (3个月) 771,728
市值 23,399,657,472
预期市盈率 (P/E Forward) 12.72
价格/销量 (P/S) 1.29
股市价格/股市净资产 (P/B) 1.86
52周波幅
19.55 (-22%) — 32.91 (31%)
利润日期 11 Feb 2025
营业毛利率 -1.82%
营业利益率 (TTM) 7.72%
稀释每股收益 (EPS TTM) -0.510
季度收入增长率 (YOY) -2.10%
季度盈利增长率 (YOY) 105.70%
总债务/股东权益 (D/E MRQ) 69.35%
流动比率 (MRQ) 1.16
营业现金流 (OCF TTM) 1.80 B
杠杆自由现金流 (LFCF TTM) 1.85 B
资产报酬率 (ROA TTM) 1.36%
股东权益报酬率 (ROE TTM) -4.59%

市场趋势

短期 中期
行业 Medical Devices (US) 混合的 混合的
Medical Devices (全球的) 混合的 混合的
股票 Koninklijke Philips N.V. NY Reg - -

AIStockmoo 评分

-0.2
分析师共识 NA
内部交易活动 NA
价格波动 -2.0
技术平均移动指标 3.5
技术振荡指标 -2.0
平均 -0.17

相关股票

股票 市值 DY P/E(TTM) P/B
PHG 23 B - - 1.86
BSX 143 B - 79.93 6.75
SYK 139 B 0.89% 39.08 6.83
ABT 204 B 1.93% 35.47 5.04
MDT 102 B 3.49% 24.43 2.25
GMED 11 B - 135.39 2.91

Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal care products.

部门 Healthcare
行业 Medical Devices
投资方式 Large Core
机构持股比例 6.87%

所有权

姓名 日期 持有股份
Exor N.V. 30 Sep 2024 164,553,857

该时间范围内无数据。

该时间范围内无数据。

日期 类型 细节
09 Jan 2025 公告 Philips appoints Jie Xue as Chief Business Leader Precision Diagnosis, co-leader of the Diagnosis & Treatment segment, and Özlem Fidanci as Chief of International Region
09 Jan 2025 公告 Philips appoints Jie Xue as Chief Business Leader Precision Diagnosis, co-leader of the Diagnosis & Treatment segment, and Özlem Fidanci as Chief of International Region
09 Dec 2024 公告 NEFHSC, Baptist Health & Philips Give Local Families Free Pregnancy+ App
03 Dec 2024 公告 Philips aims to advance cardiac MRI technology through AI-driven research
03 Dec 2024 公告 Philips aims to advance cardiac MRI technology through AI-driven research
01 Dec 2024 公告 Philips optimizes CT workflows with in-house AI, launches CT 5300 in North America at #RSNA2024
01 Dec 2024 公告 Philips optimizes CT workflows with in-house AI, launches CT 5300 in North America at #RSNA2024
01 Dec 2024 公告 Better care for more people: Philips innovates in AI-enabled imaging and cloud-based informatics at #RSNA24
01 Dec 2024 公告 Better care for more people: Philips innovates in AI-enabled imaging and cloud-based informatics at #RSNA24
26 Nov 2024 公告 Philips and AWS expand strategic collaboration to advance HealthSuite cloud services and power generative AI workflows
26 Nov 2024 公告 Philips and AWS expand strategic collaboration to advance HealthSuite cloud services and power generative AI workflows
25 Nov 2024 公告 Philips and icometrix advance precision diagnosis in neurology with innovative AI-based imaging solutions at #RSNA24
25 Nov 2024 公告 Philips and icometrix advance precision diagnosis in neurology with innovative AI-based imaging solutions at #RSNA24
22 Nov 2024 公告 Philips advances remote imaging leadership with FDA 510(k) clearance for innovative remote scanning and protocol management capabilities
21 Nov 2024 公告 Philips unveils next-generation BlueSeal helium-free MRI system, integrated with AI-enabled Smart Reading at #RSNA24
21 Nov 2024 公告 Philips unveils next-generation BlueSeal helium-free MRI system, integrated with AI-enabled Smart Reading at #RSNA24
13 Nov 2024 公告 Philips Norelco and actor Adam Scott pay tribute to "The King of Beards" this holiday
12 Nov 2024 公告 Philips Spectral CT 7500 RT, world’s first spectral 4DCT respiratory-gated imaging receives FDA 510(k) clearance
04 Nov 2024 公告 Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease
04 Nov 2024 公告 Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease
30 Oct 2024 公告 Philips and Aspen Dental launch multi-year Sonicare-brand partnership
29 Oct 2024 公告 Philips to Further Roll Out RATE: AI for Early Infection Detection at U.S. Department of Defense Through Four-Year, $25 Million Contract
28 Oct 2024 公告 Philips delivers strong margin improvement; flat comparable sales due to further deteriorated demand in China; growth in rest of world
28 Oct 2024 公告 Philips delivers strong margin improvement; flat comparable sales due to further deteriorated demand in China; growth in rest of world
24 Oct 2024 公告 Philips and Medtronic advocacy partnership aims to help accelerate access to life-saving treatments
24 Oct 2024 公告 Philips and Medtronic advocacy partnership aims to help accelerate access to life-saving treatments
21 Oct 2024 公告 Philips showcases next level cardiology innovations for improved patient care at TCT 2024
显示更多
5年平均股息收益率 1.78%
除息日 公告日期 支付日期 详情
12 May 2022 07 Jun 2022 08 Jun 2022 0.912092 现金
10 May 2021 25 Jan 2021 09 Jun 2021 1.034025 现金
13 May 2019 19 Apr 2019 13 Jun 2019 0.961222 现金
07 May 2018 31 Jan 2018 06 Jun 2018 0.9394 现金
12 May 2017 - 14 Jun 2017 0.762926 现金
13 May 2016 - 15 Jun 2016 0.766224 现金
08 May 2015 - 10 Jun 2015 0.759016 现金
05 May 2014 - 04 Jun 2014 0.925548 现金
07 May 2013 - 05 Jun 2013 0.82926 现金
02 May 2012 - 31 May 2012 0.801082 现金
04 Apr 2011 - 04 May 2011 0.945859 现金
29 Mar 2010 - 28 Apr 2010 0.792599 现金
30 Mar 2009 - 07 Apr 2009 0.796824 现金
28 Mar 2008 - 07 Apr 2008 1.09424 现金
30 Mar 2007 - 10 Apr 2007 0.80112 现金
31 Mar 2006 - 10 Apr 2006 0.53953 现金
01 Apr 2005 - 11 Apr 2005 0.5144 现金
26 Mar 2004 - 05 Apr 2004 0.44006 现金
28 Mar 2003 - 07 Apr 2003 0.38988 现金
02 Apr 2002 - 08 Apr 2002 0.31709 现金
30 Mar 2001 - 18 Apr 2001 0.31975 现金
27 Jul 2000 - 04 Aug 2000 1.168776 现金
05 Apr 2000 - 19 Apr 2000 1.14288 现金
26 May 1999 - 03 Jun 1999 4.289884 现金
26 Mar 1999 - 14 Apr 1999 1.08717 现金
17 Mar 1998 - 03 Apr 1998 0.9712 现金
24 Mar 1997 - 11 Apr 1997 0.84818 现金
26 Mar 1996 - 16 Apr 1996 0.82155 现金
03 May 1995 - 31 May 1995 0.68192 现金
显示更多

每年股息收益率

年份 每年总股息 ($) 频率/年份 收益率 %
2022 0.912 1 6.09
2021 1.03 1 2.81
2019 0.961 1 1.97
2018 0.939 1 2.68
2017 0.763 1 2.02
2016 0.766 1 2.51
2015 0.759 1 2.98
2014 0.926 1 3.19
2013 0.829 1 2.24
2012 0.801 1 3.02
2011 0.946 1 4.52
2010 0.793 1 2.58
2009 0.797 1 2.71
2008 1.09 1 5.51
2007 0.801 1 1.87
2006 0.540 1 1.44
2005 0.514 1 1.65
2004 0.440 1 1.66
2003 0.390 1 1.34
2002 0.317 1 1.79
2001 0.320 1 1.10
2000 2.31 2 6.38
1999 5.38 2 15.93
1998 0.971 1 5.74
1997 0.848 1 5.61
1996 0.822 1 8.22
1995 0.682 1 7.60
显示更多

支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2025 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票